Discovered cancers at postmortem donor examination: A starting point for quality improvement of donor assessment

Ilaria Girolami, Desley Neil, Dorry Lidor Segev, Lucrezia Furian, Gianluigi Zaza, Ugo Boggi, Giovanni Gambaro, Tullia De Feo, Marilena Casartelli-Liviero, Massimo Cardillo, Letizia Lombardini, Laura Zampicinini, Antonietta D'Errico, Albino Eccher

Research output: Contribution to journalReview articlepeer-review


Background: clinical and imaging investigations allow a detailed assessment of an organ donor, but a quota of cancer still elude detection. Complete autopsy of donors is even less frequently performed, due to economic issues and increasing availability of high-quality imaging. The aim of this study is to gather evidence from the literature on donor malignancy discovered at autopsy following organ donation and to discuss the utility and limitations of autopsy practice in the field of transplantation. Methods: A systematic search according to PRISMA guidelines was carried out in Pubmed and Embase databases until September 2020 to select articles with reporting of cancer discovered in a donor at postmortem examination. Cancer discover in not-transplant setting were excluded. A descriptive synthesis was provided. Results: Of 7388 articles after duplicates removal, 56 were included. Fifty-one studies reported on complete autopsy, while 5 dealt only with limited autopsy (prostate and central nervous system). The number of autopsies ranged between 1 and 246 with a total of 823 autopsies performed. The most frequent cancer discovered at autopsy was lymphoma (n = 13, 15%), followed by renal cell carcinoma (RCC) (n = 11, 13%), non-small cell lung cancer (NSCLC) (n = 10, 11%), melanoma (n = 10, 11%), choriocarcinoma (n = 6, 7%) and glioblastoma (GBM) (n = 6, 7%). Conclusions: Lymphoma and melanoma are still difficult-to-detect cancers both during donor investigation and at procurement, whilst prostate cancer and choriocarcinoma are almost always easily detected nowadays thank to blood markers and clinical examination. There have been improvements with time in pre-donation detection procedures which are now working well, particularly when complete imaging investigations are performed, given that detection rate of CT/MRI is high and accurate. Autopsy can play a role to help to establish the correct donor management pathways in case of cancer discover. Furthermore, it helps to better understand which cancers are still eluding detection and consequently to refine guidelines' assessment procedures.

Original languageEnglish
Article number100608
JournalTransplantation Reviews
Issue number2
Publication statusPublished - Apr 2021


  • Autopsy
  • Cancer
  • Organ donor
  • Postmortem
  • Transplantation

ASJC Scopus subject areas

  • Transplantation


Dive into the research topics of 'Discovered cancers at postmortem donor examination: A starting point for quality improvement of donor assessment'. Together they form a unique fingerprint.

Cite this